When he began making angel investments, Jim Powers, CEO of Charlottesville, Virginia-based drug discovery company HemoShear, put $50,000 into two biomedical firms. Eventually, venture capital was needed, and Powers’ investments were diluted to a valuation of about $1,000 each. He says he now realizes that this was probably inevitable, but it’s not something he understood then.
